CAMK2D and diabetes mellitus: Future studies will aim to test additional nonviral delivery strategies and to determine whether CAMK2D editing is also beneficial to a broader range of cardiovascular diseases, as oxidized CaMKIIδ has been linked to numerous disorders like atrial fibrillation, diabetes mellitus, and sleep-disordered breathing (3, 15, 16, 40).